Asan Medical Center
CyberKnife for brain tumor in Republic of Korea typically costs from AUD $16,486 to AUD $26,521. Prices depend on the specific machine model, hospital tier, and the number of treatment sessions required. Patients save around 41% by travelling to the Republic of Korea from Australia, where this procedure costs AUD $36,270 on average. Most quotes cover the radiosurgery itself and clinical treatment planning.
Bookimed Expert Insight: Choosing a "Big 5" hospital in Seoul provides security for complex neurosurgery. Severance Hospital holds JCI accreditation, meaning its quality systems meet rigorous international standards. For high-volume care, Asan Medical Center performs over 65,000 operations annually. Many find the slightly higher premium in Seoul worthwhile for access to doctors who specialise in specific tumor types.
| Republic of Korea | Thailand | Turkey | |
| CyberKnife for brain tumor | from AUD $16,486 | from AUD $50,175 | from AUD $6,810 |
No hidden fees – just official clinic prices. Pay at the clinic for CyberKnife for brain tumor upon arrival and use a flexible instalment plan if needed.
Bookimed is committed to your safety. We only work with medical institutions that maintain high international standards in CyberKnife for brain tumor and have the necessary licenses to serve international patients worldwide.
Bookimed offers free expert assistance. A personal medical coordinator supports you before, during, and after your treatment, solving any issues. You're never alone on your CyberKnife for brain tumor journey.
CyberKnife is a highly effective, non-invasive treatment for brain metastases in South Korea. JCI-accredited clinics in Seoul use robotic stereotactic radiosurgery to deliver high-dose radiation with sub-millimetre precision. This eliminates the need for invasive head frames while sparing healthy brain tissue and critical structures like the brainstem.
Bookimed Expert Insight: Gamma Knife is often the standard for brain lesions. However, South Korea’s top centres like Severance Hospital partner with institutions like MD Anderson. These partnerships mean Korean specialists use CyberKnife for complex cases. This is especially true when tumours are located near the brainstem, where surgical access is too risky.
Patient Consensus: The procedure is painless and tumours often shrink or disappear completely without returning. Most patients drive themselves home immediately after sessions and experience only mild, temporary fatigue.
Major South Korean hospitals in Seoul and Gyeonggi-do provide CyberKnife for brain tumours. Institutions such as Seoul National University Cancer Hospital and Incheon St. Mary's Hospital offer this non-invasive radiosurgery. The treatment precisely targets tumour tissue while protecting healthy brain cells without open surgery.
Bookimed Expert Insight: Patients often travel to Seoul specifically for CyberKnife. It treats tumours Gamma Knife cannot reach. Gamma Knife is the brain surgery gold standard. However, CyberKnife is often preferred for tumours located near the spine or skull base.
Patient Consensus: Visitors to Seoul appreciate the clear coordination and comprehensive testing before treatment. Getting a detailed plan and cost estimate upfront helps avoid surprises during the medical holiday.
South Korea offers brain tumour patients non-invasive CyberKnife treatment with sub-millimetre precision at JCI-accredited Seoul hospitals. Patients access radiosurgery from A$$11,500, saving up to 84% compared to Australian averages. High-volume centres like Severance Hospital combine robotic accuracy with expertise from world-ranked oncology specialists.
Bookimed Expert Insight: While many choose South Korea for cost, the real advantage is the multidisciplinary approach. At Asan Medical Center, a personal coordinator manages everything while specialists from 88 departments collaborate. This level of integrated care for complex brain tumours is rarely available at this price point elsewhere.
Patient Consensus: Patients value how CyberKnife halts tumour growth without the risks of open surgery. Most return to daily life within days, reporting only mild fatigue as a side effect.
CyberKnife is a non-invasive robotic radiosurgery system. In South Korea, it is used to treat brain tumours without surgery. It uses a robotic arm to deliver high-dose radiation beams with millimetre precision. The system tracks head movement in real-time, protecting healthy brain tissue during outpatient sessions.
Bookimed Expert Insight: Many countries use Gamma Knife. However, South Korean centres like Severance Hospital lead in robotic CyberKnife technology. This is crucial for tumours near critical structures. The robotic arm eliminates the need for rigid frames. This makes treatment far more comfortable for patients.
Patient Consensus: Treatment in South Korea is painless and fast, allowing patients to drive home immediately. Most people report mild fatigue as the only side effect. Tumours show no growth for years.
CyberKnife treatment for brain tumours in South Korea typically requires 1 to 5 sessions. These non-invasive radiosurgery visits are completed within 1 to 2 weeks. The exact number of treatments depends on the tumour type and size. It also depends on proximity to critical structures like the optic nerve.
Bookimed Expert Insight: GammaKnife is more common at major Seoul centres like Asan Medical Center. However, CyberKnife offers a distinct advantage for tumours near the skull base. CyberKnife does not require a metal head frame bolted to the skull. This makes it a preferred choice for patients needing multiple sessions over several days.
Patient Consensus: Patients found the sessions quick and painless, often returning to their hotels immediately. Success in South Korea often involves 3 sessions for secondary tumours. Many patients appreciate the frame-free comfort.